New approaches to understanding Alzheimer's and Parkinson's disease

July 26, 2016, Alzheimer's Research UK

In a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explored how some people may develop the hallmarks of Alzheimer's or Parkinson's but never develop symptoms.

Alzheimer's is typified by the build-up of in the brain, and Parkinson's disease by the loss of a key chemical messenger in the brain called dopamine.

However, it's becoming clear that individuals can exhibit these changes but show no changes in their memory, thinking or day-to-day function. Using brain imaging data from large-scale studies into both diseases, the team identified regions of the brain associated with resilience to these changes, such as a key region in the memory centre of the brain which was preserved despite the build-up of amyloid.

By mapping these potential protective networks in the brain, the researchers hope to identify potential new approaches to treat the disease as well as ways to indicate those most at risk.

Dr Rosa Sancho, Head of Research at Alzheimer's Research UK, said:

"The observation that some individuals can exhibit Alzheimer's or Parkinson's disease changes in their without showing any symptoms has raised important questions for researchers trying to tackle these diseases. This study suggests that there may be differences in the brains of individuals who are more resilient to diseases like Alzheimer's, providing clues to what may be most important for that protection. Understanding the mechanisms underpinning resilience to across the population can help to uncover new targets for treatments or approaches to intervene to delay the onset in those most at risk."

Explore further: Genetic and non-genetic resilience against memory decline and Alzheimer's

Related Stories

Genetic and non-genetic resilience against memory decline and Alzheimer's

July 25, 2016
Researchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016, two teams of researchers are presenting findings revealing clues ...

'Pac-Man' gene implicated in Alzheimer's disease

July 26, 2016
A gene that protects the brain from the harmful build-up of amyloid-beta, one of the causative proteins implicated in Alzheimer's disease, has been identified as a new target for therapy by NeuRA researchers.

Changes in blood flow to the brain may be early feature of Alzheimer's disease

June 22, 2016
A new study has shown that changes in blood flow to different brain areas may be one of the earliest changes in the brain linked to Alzheimer's disease. The research is published today in the journal Nature Communications.

Alzheimer's researchers investigate diabetes link in mice

June 22, 2016
Researchers in Aberdeen have highlighted a possible new link between Alzheimer's disease and diabetes according to a new study published today in the journal Diabetologia.

Occupational complexity linked to better cognitive performance after damage to the brain's white matter

July 25, 2016
Researchers in the US have presented findings indicating that individuals who have a history of complex occupations, involving work with other people, are better able to maintain memory and thinking skills in the presence ...

Diabetes drug could influence brain activity in Alzheimer's

April 28, 2016
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.